AAAAAA

   
Results: 1-7 |
Results: 7
Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation
Authors: Dowlati, A Haaga, J Remick, SC Spiro, TP Gerson, SL Liu, LL Berger, SJ Berger, NA Willson, JKV
Citation: A. Dowlati et al., Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation, CLIN CANC R, 7(10), 2001, pp. 2971-2976
Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer
Authors: Dowlati, A Levitan, N Gordon, NH Hoppel, CL Gosky, DM Remick, SC Ingalls, ST Berger, SJ Berger, NA
Citation: A. Dowlati et al., Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer, CANC CHEMOT, 47(2), 2001, pp. 141-148
X-ray-induced damage repair in exponentially growing and growth arrested confluent poly(adenosine diphosphate-ribose) polymerase-deficient V79 Chinese hamster cell line
Authors: Chatterjee, S Berger, NA
Citation: S. Chatterjee et Na. Berger, X-ray-induced damage repair in exponentially growing and growth arrested confluent poly(adenosine diphosphate-ribose) polymerase-deficient V79 Chinese hamster cell line, INT J ONCOL, 17(5), 2000, pp. 955-962
Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients
Authors: Takimoto, CH Morrison, G Harold, N Quinn, M Monahan, BP Band, RA Cottrell, J Guemei, A Llorens, V Hehman, H Ismail, AS Flemming, D Gosky, DM Hirota, H Berger, SJ Berger, NA Chen, AP Shapiro, JD Arbuck, SG Wright, J Hamilton, JM Allegra, CJ Grem, JL
Citation: Ch. Takimoto et al., Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients, J CL ONCOL, 18(3), 2000, pp. 659-667
Detection of poly(ADP-ribose) polymerase cleavage in response to treatmentwith topoisomerase I inhibitors: A potential surrogate end point to assesstreatment effectiveness
Authors: Whitacre, CM Zborowska, E Willson, JKV Berger, NA
Citation: Cm. Whitacre et al., Detection of poly(ADP-ribose) polymerase cleavage in response to treatmentwith topoisomerase I inhibitors: A potential surrogate end point to assesstreatment effectiveness, CLIN CANC R, 5(3), 1999, pp. 665-672
Poly(ADP-ribose)polymerase: A guardian of the genome that facilitates DNA repair by protecting against DNA recombination
Authors: Chatterjee, S Berger, SJ Berger, NA
Citation: S. Chatterjee et al., Poly(ADP-ribose)polymerase: A guardian of the genome that facilitates DNA repair by protecting against DNA recombination, MOL C BIOCH, 193(1-2), 1999, pp. 23-30
Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation
Authors: Belfi, CA Chatterjee, S Gosky, DM Berger, SJ Berger, NA
Citation: Ca. Belfi et al., Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation, BIOC BIOP R, 257(2), 1999, pp. 361-368
Risultati: 1-7 |